Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MiRNA Fingerprint Identified in Platelet Formation

17.03.2006


Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets – blood cells critical to the body’s ability to form clots following an injury. They also say some of these same miRNAs, when acting abnormally, may contribute to certain forms of leukemia.



“Basically, we found that a specific set of miRNA genes are turned off in normal platelet development, but turned on in certain platelet-related leukemia cells,” says lead author Dr. Ramiro Garzon, a clinical instructor in The Ohio State University College of Medicine.

The study is published online in the Proceedings of the National Academy of Sciences.


MiRNA has only recently been acknowledged as an important force in biology. For decades, scientific dogma has held that messenger RNA (mRNA) was responsible for carrying out DNA instructions, or code, for protein production in the cell. Little was known, however, about how cells actually regulated that process. But over the past 10 years, researchers have discovered that miRNA – tiny fragments of RNA typically no more than 20-25 nucleotides in length – also regulates protein synthesis by interfering with mRNA’s original instructions. They now know that miRNA helps to regulate many key biological processes, including cell growth, death, development and differentiation.

Dr. Carlo Croce, director of Ohio State’s Human Cancer Genetics Program, was the first to discover a link between miRNA and cancer. In the current study, Croce, who is also a member of the OSU Comprehensive Cancer Center, along with Garzon and colleagues from the M.D. Anderson Cancer Center, examined miRNA activity in the earliest phases of platelet development.

The researchers had previously uncovered substantial evidence linking certain patterns of miRNA to both normal and abnormal blood cell development, especially in diseases like chronic lymphocytic leukemia and lymphoma. Relatively little was known, however, about miRNA functionality in platelet formation.

Platelets are created from stem cells in the bone marrow. They evolve through a process called megakaryocytopoiesis, which generates megakaryocytes, or platelet parent cells.

The research team used microRNA gene chip analysis to identify miRNA expression in normal stem cells and megakaryoctyes. They also studied miRNA expression patterns in four acute megakaryoblastic leukemia (AMKL) cell lines. They discovered that a set of 17 miRNAs are turned off during normal megakaryocyte differentiation and that 8 of those genes create a molecular signature that clearly defines a megakaryocyte from any other type of cell.

“We believe this set of genes may contribute to platelet formation,” says Garzon. “We think that when these miRNAs are turned off, it’s a signal to other gene targets to get busy with the normal process of development.” Garzon says just the opposite happens in AMKL, an unusual form of leukemia more often found in children than adults.

In examining four sets of AMKL lines, they found that 10 miRNAs were turned on, again representing a molecular signature for that disease. “Interestingly, half of that number are also members of the miRNA profile in normal platelet cell development – suggesting that this small subset may be most important in understanding how AMKL develops, says Garzon.

Researchers believe that more knowledge about miRNA could lead to a new class of targeted therapies that may be helpful in treating leukemia and other diseases. “That day, however, is still a long way off,” says Garzon.

Grants from the National Cancer Institute, the Leukemia & Lymphoma Society, the Kimmel Foundation and a CLL Research Foundation Grant helped support the study.

Additional co-authors from OSU’s department of molecular virology, immunology and medical genetics include Flavia Pichiorri, Tizaiana Palumbo, Rodolfo Iuliano, Amelia Cimmino, Rami Aqeilan, Stefano Volinia, Darshna Bhatt, Hansjuerg Alder, Guido Marcucci, George Calin, Chang-Gong Liu and Clara Bloomfield. Michael Andreeff, who also helped with the study, is from the M.D. Anderson Cancer Center.

Michelle Gailiun | EurekAlert!
Further information:
http://www.osu.edu

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>